Physician profile
Marisa Ann Ryan
NPI 1346567369
$869.11
in general payments reported to CMS, 2019-2025
9 companies · $467 in 2025
The $467 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.10 · 2022: $40.78 · 2023: $215 · 2024: $64.51 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699 · Education: $47.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.01 |
| Education | $47.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $217.47 | 2023-2025 | Tula, Halo |
| Stryker Corporation | $215.90 | 2023-2025 | Scopis Ent, Xpress Ent Dilation System |
| Olympus America INC. | $148.65 | 2025 | Connecting Tube, Rhino-Laryngo Videoscope |
| Novartis Pharmaceuticals Corporation | $103.38 | 2022-2024 | |
| Acclarent, INC | $82.10 | 2019 | |
| Precigen, INC. | $47.22 | 2025 | |
| Mallinckrodt Hospital Products INC. | $18.75 | 2022 | |
| Amgen INC. | $18.72 | 2023 | Amjevita |
| Rhythm Pharmaceuticals, INC. | $16.92 | 2023 | Imcivree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marisa Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.